PL
Daewoong Pharmaceutical Co., Ltd., Republic of Korea
On Hwang, MS.
Team Leader of Formulation Research, Daewoong Pharmaceutical Company
I currently serves as the Head of Formulation Research at Daewoong Pharmaceutical Company. Throughout my career, I has led the development of the company’s flagship drugs, Envlo and Fexuclue, as well as multiple fixed-dose combinations and controlled-release formulations, contributing significantly to the company’s pipeline of innovative and value-added medicines.
With more than a decade of hands-on experience in oral solid dosage development, I has specialized in bridging early-stage formulation design to commercial-scale manufacturing, successfully driving both incremental innovation and differentiated product development. My leadership in complex generics and improved new drugs has positioned Daewoong Pharmaceutical Company as a competitive player in the domestic market.